12:00 AM
 | 
Mar 05, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

U.S. Food and Drug Administration (FDA) regulatory update

FDA will hold a public hearing on March 22-23 to discuss a potential pathway for OTC approval of products that would otherwise be available only by prescription. FDA is seeking comments on what types of evidence would be needed to show that...

Read the full 187 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >